News

RSS feed

handicap.fr

Non-profit Drugs: a first in France!

Thanks to a new decree, “Drugs for innovative therapy”, Genethon, the AFM-Telethon laboratory, will be able to commercialize products from its research. A first in the non-profit arena.

Author(s) : Handicap.fr – E.Dal’Secco http://www.handicap.fr

Read the article [PDF – 18,7 ko]

handicapinfos.com

“Drugs for innovative therapies”: a new step for AFM-Telethon and its Genethon laboratory.

Read the article [PDF – 21,4 ko]

Pharmaceutiques

Gene Therapy: The industrial era begins

Read the article [PDF in French – 764ko]

Le Quotidien du médecin

Winner fot the “Prix Galien France 2012” in a state of uncertainty: Genethon is stuck in the starting blocks

Biofutur

Bioproduction arrives in France.

by Agnès Vernet

Le Parisien

A “Nobel Prize” for Genethon

(Reporter : Julien Heyligen)

Genethon Lecture Series:2012, November 30th

Friday November 30th, 2012: « Developing antisense oligonucleotides as a genetic therapy for Duchenne Muscular Dystrophy » Pr Francesco Muntoni, Professor of Paediatric Neurology, UCL Institute of Child Health and Great Ormond Street Hospital for Children (GOSH), Dubowitz Neuromuscular Centre, London, UK.

LesEchos.fr

In Biology, “Big is beautiful”

The Biotherapies Institute which has just been created will include 650 scientists on 4 sites.

L’Express

Genethon, member of the Biothérapies Institute for Rare Diseases

Rare diseases: an Institute which is unique in the world

Pharmaceutiques

Genethon, member of the Biothérapies Institute for Rare Diseases